BackInozyme Pharma Overview

Inozyme Pharma Total Liabilities

Track Inozyme Pharma's total liabilities ($63M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$63.37M
↑ 9.05% YoYΔ $5.26M vs prior year quarter

Peer trimmed avg / median

Loading

Inozyme Pharma Total Liabilities History

Loading

Inozyme Pharma vs. peers: Total Liabilities Comparison

Loading

Inozyme Pharma Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Inozyme Pharma (INZY) FAQ

As of the most recent data (March 2025), INZY shows a total liabilities of $63M. That compares with $58M in the prior-year period — up 9.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INZY's total liabilities is now $63M (was $58M) — a 9.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Inozyme Pharma is outperforming or lagging.

Tracking INZY's total liabilities over time shows whether Inozyme Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $63M That compares with $58M in the prior-year period — up 9.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Inozyme Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $63M) with ownership activity and broader fundamentals.

Inozyme Pharma's total liabilities is $63M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.